Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bieber

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Blood Purification|January 1, 1993
Antibody-based immunoadsorption as a therapeutic meansA du Moulin, J Müller-Derlich, F Bieber, et al.
Neurology|May 22, 1998
Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's diseaseJ C Morris, P A Cyrus, J Orazem, et al.
Life Sciences|May 19, 1998
Safety and tolerability of metrifonate in patients with Alzheimer's disease: results of a maximum tolerated dose studyN R Cutler, S S Jhee, P Cyrus, et al.
Plos One|October 7, 2021
Why the Stall? Using metabolomics to define the lack of upstream movement of invasive bigheaded carp in the Illinois RiverJocelyn A Curtis-Quick, Alexander V Ulanov, Zhong Li, et al.
Dementia and Geriatric Cognitive Disorders|July 17, 2001
The Bayer-Activities of Daily Living Scale (B-ADL): results from a validation study in three European countriesH Erzigkeit, H Lehfeld, J Peña-Casanova, et al.
Journal of Clinical Pharmacology|April 29, 1998
Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's diseaseL C Pettigrew, F Bieber, J Lettieri, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Blood Purification|January 1, 1993
Antibody-based immunoadsorption as a therapeutic meansA du Moulin, J Müller-Derlich, F Bieber, et al.
Neurology|May 22, 1998
Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's diseaseJ C Morris, P A Cyrus, J Orazem, et al.
Life Sciences|May 19, 1998
Safety and tolerability of metrifonate in patients with Alzheimer's disease: results of a maximum tolerated dose studyN R Cutler, S S Jhee, P Cyrus, et al.
Plos One|October 7, 2021
Why the Stall? Using metabolomics to define the lack of upstream movement of invasive bigheaded carp in the Illinois RiverJocelyn A Curtis-Quick, Alexander V Ulanov, Zhong Li, et al.
Dementia and Geriatric Cognitive Disorders|July 17, 2001
The Bayer-Activities of Daily Living Scale (B-ADL): results from a validation study in three European countriesH Erzigkeit, H Lehfeld, J Peña-Casanova, et al.
Journal of Clinical Pharmacology|April 29, 1998
Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's diseaseL C Pettigrew, F Bieber, J Lettieri, et al.
Pageof 2